John Verbanac, PhD

Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Care Systems

Background: Treatment resistant depression (TRD) is burdensome to health systems. Earlier identification of at-risk patients may reduce clinical inertia and improve outcomes.

Jacqueline Pesa , PhD, MPH;

Charles Ruetsch , PhD;

Joshua Liberman , PhD;

Tigwa Davis , PhD;

Sara Heverly-Fitt , PhD;

John Verbanac , PhD;

Wing Chow , PharmD, MPH;

11/22/2019

Descriptive Patterns Emerging From Initial Antidepressant Treatment Episodes in Patients with Treatment-Resistant Depression

Background: TRD leads to excess healthcare costs and burden of illness. Early patterns of antidepressant use may signify patients at high-risk for TRD. Methods: Eligible patients with ma...

John Verbanac , PhD;

Wing Chow , PharmD, MPH;

Jacqueline Pesa , PhD, MPH;

Charles Ruetsch , PhD;

Joshua Liberman , PhD;

Tigwa Davis , PhD;

Sara Heverly-Fitt , PhD;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

April 30 ⁠–⁠ May 5

WoundCon

May 1 ⁠–⁠ May 3

May 19 ⁠–⁠ May 21

See Full Calendar